United States Immune Checkpoint Blockers Market Report 2017

United States Immune Checkpoint Blockers Market Report 2017

1 Immune Checkpoint Blockers Overview

1.1 Product Overview and Scope of Immune Checkpoint Blockers

1.2 Classification of Immune Checkpoint Blockers by Product Category

1.2.1 United States Immune Checkpoint Blockers Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Immune Checkpoint Blockers Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Anti-PD-L1 Drug

1.2.4 Anti-PD-1 Drug

1.2.5 CTLA4

1.3 United States Immune Checkpoint Blockers Market by Application/End Users

1.3.1 United States Immune Checkpoint Blockers Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Lung Cancer

1.3.3 Colorectal Cancer

1.3.4 Breast Cancer?

1.3.5 Prostate Cancer

1.3.6 Melanoma

1.3.7 Blood Cancers

1.4 United States Immune Checkpoint Blockers Market by Region

1.4.1 United States Immune Checkpoint Blockers Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Immune Checkpoint Blockers Status and Prospect (2012-2022)

1.4.3 Southwest Immune Checkpoint Blockers Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Immune Checkpoint Blockers Status and Prospect (2012-2022)

1.4.5 New England Immune Checkpoint Blockers Status and Prospect (2012-2022)

1.4.6 The South Immune Checkpoint Blockers Status and Prospect (2012-2022)

1.4.7 The Midwest Immune Checkpoint Blockers Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Immune Checkpoint Blockers (2012-2022)

1.5.1 United States Immune Checkpoint Blockers Sales and Growth Rate (2012-2022)

1.5.2 United States Immune Checkpoint Blockers Revenue and Growth Rate (2012-2022)

2 United States Immune Checkpoint Blockers Market Competition by Players/Suppliers

2.1 United States Immune Checkpoint Blockers Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Immune Checkpoint Blockers Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Immune Checkpoint Blockers Average Price by Players/Suppliers (2012-2017)

2.4 United States Immune Checkpoint Blockers Market Competitive Situation and Trends

2.4.1 United States Immune Checkpoint Blockers Market Concentration Rate

2.4.2 United States Immune Checkpoint Blockers Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Immune Checkpoint Blockers Manufacturing Base Distribution, Sales Area, Product Type

3 United States Immune Checkpoint Blockers Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Immune Checkpoint Blockers Sales and Market Share by Region (2012-2017)

3.2 United States Immune Checkpoint Blockers Revenue and Market Share by Region (2012-2017)

3.3 United States Immune Checkpoint Blockers Price by Region (2012-2017)

4 United States Immune Checkpoint Blockers Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Immune Checkpoint Blockers Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Immune Checkpoint Blockers Revenue and Market Share by Type (2012-2017)

4.3 United States Immune Checkpoint Blockers Price by Type (2012-2017)

4.4 United States Immune Checkpoint Blockers Sales Growth Rate by Type (2012-2017)

5 United States Immune Checkpoint Blockers Sales (Volume) by Application (2012-2017)

5.1 United States Immune Checkpoint Blockers Sales and Market Share by Application (2012-2017)

5.2 United States Immune Checkpoint Blockers Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Immune Checkpoint Blockers Players/Suppliers Profiles and Sales Data

6.1 Bristol Myers Squibb

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Immune Checkpoint Blockers Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Bristol Myers Squibb Immune Checkpoint Blockers Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Merck

6.2.2 Immune Checkpoint Blockers Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Merck Immune Checkpoint Blockers Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 AstraZeneca

6.3.2 Immune Checkpoint Blockers Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 AstraZeneca Immune Checkpoint Blockers Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Roche

6.4.2 Immune Checkpoint Blockers Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Roche Immune Checkpoint Blockers Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

...

7 Immune Checkpoint Blockers Manufacturing Cost Analysis

7.1 Immune Checkpoint Blockers Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Immune Checkpoint Blockers

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Immune Checkpoint Blockers Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Immune Checkpoint Blockers Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Immune Checkpoint Blockers Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Immune Checkpoint Blockers Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Immune Checkpoint Blockers Sales Volume Forecast by Type (2017-2022)

11.3 United States Immune Checkpoint Blockers Sales Volume Forecast by Application (2017-2022)

11.4 United States Immune Checkpoint Blockers Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Immune Checkpoint Blockers

Figure United States Immune Checkpoint Blockers Market Size (K Units) by Type (2012-2022)

Figure United States Immune Checkpoint Blockers Sales Volume Market Share by Type (Product Category) in 2016

Figure Anti-PD-L1 Drug Product Picture

Figure Anti-PD-1 Drug Product Picture

Figure CTLA4 Product Picture

Figure United States Immune Checkpoint Blockers Market Size (K Units) by Application (2012-2022)

Figure United States Sales Market Share of Immune Checkpoint Blockers by Application in 2016

Figure Lung Cancer Examples

Table Key Downstream Customer in Lung Cancer

Figure Colorectal Cancer Examples

Table Key Downstream Customer in Colorectal Cancer

Figure Breast Cancer? Examples

Table Key Downstream Customer in Breast Cancer?

Figure Prostate Cancer Examples

Table Key Downstream Customer in Prostate Cancer

Figure Melanoma Examples

Table Key Downstream Customer in Melanoma

Figure Blood Cancers Examples

Table Key Downstream Customer in Blood Cancers

Figure United States Immune Checkpoint Blockers Market Size (Million USD) by Region (2012-2022)

Figure The West Immune Checkpoint Blockers Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Immune Checkpoint Blockers Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Immune Checkpoint Blockers Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Immune Checkpoint Blockers Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Immune Checkpoint Blockers Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Immune Checkpoint Blockers Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Immune Checkpoint Blockers Sales (K Units) and Growth Rate (2012-2022)

Figure United States Immune Checkpoint Blockers Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Immune Checkpoint Blockers Market Major Players Product Sales Volume (K Units) (2012-2017)

Table United States Immune Checkpoint Blockers Sales (K Units) of Key Players/Suppliers (2012-2017)

Table United States Immune Checkpoint Blockers Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Immune Checkpoint Blockers Sales Share by Players/Suppliers

Figure 2017 United States Immune Checkpoint Blockers Sales Share by Players/Suppliers

Figure United States Immune Checkpoint Blockers Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Immune Checkpoint Blockers Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Immune Checkpoint Blockers Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Immune Checkpoint Blockers Revenue Share by Players/Suppliers

Figure 2017 United States Immune Checkpoint Blockers Revenue Share by Players/Suppliers

Table United States Market Immune Checkpoint Blockers Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)

Figure United States Market Immune Checkpoint Blockers Average Price (USD/Unit) of Key Players/Suppliers in 2016

Figure United States Immune Checkpoint Blockers Market Share of Top 3 Players/Suppliers

Figure United States Immune Checkpoint Blockers Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Immune Checkpoint Blockers Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Immune Checkpoint Blockers Product Category

Table United States Immune Checkpoint Blockers Sales (K Units) by Region (2012-2017)

Table United States Immune Checkpoint Blockers Sales Share by Region (2012-2017)

Figure United States Immune Checkpoint Blockers Sales Share by Region (2012-2017)

Figure United States Immune Checkpoint Blockers Sales Market Share by Region in 2016

Table United States Immune Checkpoint Blockers Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Immune Checkpoint Blockers Revenue Share by Region (2012-2017)

Figure United States Immune Checkpoint Blockers Revenue Market Share by Region (2012-2017)

Figure United States Immune Checkpoint Blockers Revenue Market Share by Region in 2016

Table United States Immune Checkpoint Blockers Price (USD/Unit) by Region (2012-2017)

Table United States Immune Checkpoint Blockers Sales (K Units) by Type (2012-2017)

Table United States Immune Checkpoint Blockers Sales Share by Type (2012-2017)

Figure United States Immune Checkpoint Blockers Sales Share by Type (2012-2017)

Figure United States Immune Checkpoint Blockers Sales Market Share by Type in 2016

Table United States Immune Checkpoint Blockers Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Immune Checkpoint Blockers Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Immune Checkpoint Blockers by Type (2012-2017)

Figure Revenue Market Share of Immune Checkpoint Blockers by Type in 2016

Table United States Immune Checkpoint Blockers Price (USD/Unit) by Types (2012-2017)

Figure United States Immune Checkpoint Blockers Sales Growth Rate by Type (2012-2017)

Table United States Immune Checkpoint Blockers Sales (K Units) by Application (2012-2017)

Table United States Immune Checkpoint Blockers Sales Market Share by Application (2012-2017)

Figure United States Immune Checkpoint Blockers Sales Market Share by Application (2012-2017)

Figure United States Immune Checkpoint Blockers Sales Market Share by Application in 2016

Table United States Immune Checkpoint Blockers Sales Growth Rate by Application (2012-2017)

Figure United States Immune Checkpoint Blockers Sales Growth Rate by Application (2012-2017)

Table Bristol Myers Squibb Basic Information List

Table Bristol Myers Squibb Immune Checkpoint Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Bristol Myers Squibb Immune Checkpoint Blockers Sales Growth Rate (2012-2017)

Figure Bristol Myers Squibb Immune Checkpoint Blockers Sales Market Share in United States (2012-2017)

Figure Bristol Myers Squibb Immune Checkpoint Blockers Revenue Market Share in United States (2012-2017)

Table Merck Basic Information List

Table Merck Immune Checkpoint Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Merck Immune Checkpoint Blockers Sales Growth Rate (2012-2017)

Figure Merck Immune Checkpoint Blockers Sales Market Share in United States (2012-2017)

Figure Merck Immune Checkpoint Blockers Revenue Market Share in United States (2012-2017)

Table AstraZeneca Basic Information List

Table AstraZeneca Immune Checkpoint Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure AstraZeneca Immune Checkpoint Blockers Sales Growth Rate (2012-2017)

Figure AstraZeneca Immune Checkpoint Blockers Sales Market Share in United States (2012-2017)

Figure AstraZeneca Immune Checkpoint Blockers Revenue Market Share in United States (2012-2017)

Table Roche Basic Information List

Table Roche Immune Checkpoint Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Roche Immune Checkpoint Blockers Sales Growth Rate (2012-2017)

Figure Roche Immune Checkpoint Blockers Sales Market Share in United States (2012-2017)

Figure Roche Immune Checkpoint Blockers Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Immune Checkpoint Blockers

Figure Manufacturing Process Analysis of Immune Checkpoint Blockers

Figure Immune Checkpoint Blockers Industrial Chain Analysis

Table Raw Materials Sources of Immune Checkpoint Blockers Major Players/Suppliers in 2016

Table Major Buyers of Immune Checkpoint Blockers

Table Distributors/Traders List

Figure United States Immune Checkpoint Blockers Sales Volume (K Units) and Growth Rate Forecast (2017-2022)

Figure United States Immune Checkpoint Blockers Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Immune Checkpoint Blockers Price (USD/Unit) Trend Forecast (2017-2022)

Table United States Immune Checkpoint Blockers Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Immune Checkpoint Blockers Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Immune Checkpoint Blockers Sales Volume (K Units) Forecast by Type in 2022

Table United States Immune Checkpoint Blockers Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Immune Checkpoint Blockers Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Immune Checkpoint Blockers Sales Volume (K Units) Forecast by Application in 2022

Table United States Immune Checkpoint Blockers Sales Volume (K Units) Forecast by Region (2017-2022)

Table United States Immune Checkpoint Blockers Sales Volume Share Forecast by Region (2017-2022)

Figure United States Immune Checkpoint Blockers Sales Volume Share Forecast by Region (2017-2022)

Figure United States Immune Checkpoint Blockers Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources